Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study

Lizhi Zhang(Tianjin First Center Hospital), Ke Wen(Tianjin Medical University), Yanhong Wu(Shandong University of Technology), Yanmin Li(Southwest Minzu University), Quanxin Qu, Lan Lan(ZheJiang Institute For Food and Drug Control), Rong Liu(Huazhong University of Science and Technology)
Molecular and Cellular Endocrinology
August 9, 2016
Cited by 32


Related Papers